3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 1/2
1
Status
Unknown
2
Recruiting
2
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Conditions
Breast Neoplasms
69
Carcinoma, Non-Small-Cell Lung
61
Stomach Neoplasms
32
Prostatic Neoplasms
21
Nasopharyngeal Carcinoma
20
Lung Neoplasms
20
Squamous Cell Carcinoma of Head and Neck
11
Esophageal Neoplasms
10
Neoplasm Metastasis
8
Head and Neck Neoplasms
7
Inflammatory Breast Neoplasms
6
Pancreatic Neoplasms
5
Neoplasms
5
HER2-positive Breast Cancer
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
NSCLC
4
Carcinoma, Squamous Cell
4
Adenocarcinoma
4
Sarcoma
3
Nasopharyngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Ovarian Epithelial
3
Breast Diseases
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Tongue Neoplasms
2
Squamous Cell Lung Cancer
2
Interventions
Drug Therapy
4
apatinib
3
Oxaliplatin
3
Leucovorin
3
Irinotecan
3
Fluorouracil
3
pemigatinib
2
pembrolizumab
2
cemiplimab
2
avelumab
2
atezolizumab
2
S 1 (combination)
2
Nivolumab
2
Folfox protocol
2
Everolimus
2
Erlotinib Hydrochloride
2
Endoscopic Mucosal Resection
2
Docetaxel
2
Capecitabine
2
CGX1321
2
Bevacizumab
2
vandetanib
1
titanium silicide
1
tepotinib
1
tegafur-gimeracil-oteracil
1
talazoparib
1
sodium thiosulfate
1
selpercatinib
1
rucaparib
1
pralsetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Gastrointestinal Neoplasms
×
Docetaxel
×
Clear all
NCT04393584
2021-04-13
RusGCG-01
Blokhin's Russian Cancer Research Center
Phase 2/3
Unknown
538 enrolled
NCT02450656
2018-08-27
M14AFS
The Netherlands Cancer Institute
Phase 1/2
Unknown
320 enrolled